Previous Article | Next Article 
Journal of Virology, May 2005, p. 5721-5731, Vol. 79, No. 9
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.9.5721-5731.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost
Caroline S. Fernandez,1,
Ivan Stratov,1,
Robert De Rose,1
Katrina Walsh,1
C. Jane Dale,1
Miranda Z. Smith,1
Michael B. Agy,2
Shiu-lok Hu,2
Kendall Krebs,3
David I. Watkins,3
David H. O'Connor,3
Miles P. Davenport,4 and
Stephen J. Kent*
Department of Microbiology and Immunology, University of Melbourne, Victoria 3010, Australia,1
National Primate Research Centre, University of Washington, Seattle, WA 98105,2
National Primate Research Centre, University of Wisconsin, Madison WI 53715,3
Department of Haematology, Prince of Wales Hospital, and Centre for Vascular Research, University of New South Wales, Kensington, NSW 2052, Australia4
Received 8 August 2004/
Accepted 6 December 2004
Escape from specific T-cell responses contributes to the progression of human immunodeficiency virus type 1 (HIV-1) infection. T-cell escape viral variants are retained following HIV-1 transmission between major histocompatibility complex (MHC)-matched individuals. However, reversion to wild type can occur following transmission to MHC-mismatched hosts in the absence of cytotoxic T-lymphocyte (CTL) pressure, due to the reduced fitness of the escape mutant virus. We estimated both the strength of immune selection and the fitness cost of escape variants by studying the rates of T-cell escape and reversion in pigtail macaques. Near-complete replacement of wild-type with T-cell escape viral variants at an immunodominant simian immunodeficiency virus Gag epitope KP9 occurred rapidly (over 7 days) following infection of pigtail macaques with SHIVSF162P3. Another challenge virus, SHIVmn229, previously serially passaged through pigtail macaques, contained a KP9 escape mutation in 40/44 clones sequenced from the challenge stock. When six KP9-responding animals were infected with this virus, the escape mutation was maintained. By contrast, in animals not responding to KP9, rapid reversion of the K165R mutation occurred over 2 weeks after infection. The rapidity of reversion to the wild-type sequence suggests a significant fitness cost of the T-cell escape mutant. Quantifying both the selection pressure exerted by CTL and the fitness costs of escape mutation has important implications for the development of CTL-based vaccine strategies.
* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of Melbourne, Victoria 3010, Australia. Phone: 61383449939. Fax: 61383443846. E-mail: skent{at}unimelb.edu.au.
Contributed equally to the work.
Journal of Virology, May 2005, p. 5721-5731, Vol. 79, No. 9
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.9.5721-5731.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Matthews, P. C., Prendergast, A., Leslie, A., Crawford, H., Payne, R., Rousseau, C., Rolland, M., Honeyborne, I., Carlson, J., Kadie, C., Brander, C., Bishop, K., Mlotshwa, N., Mullins, J. I., Coovadia, H., Ndung'u, T., Walker, B. D., Heckerman, D., Goulder, P. J. R.
(2008). Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point. J. Virol.
82: 8548-8559
[Abstract]
[Full Text]
-
Smith, M. Z., Asher, T. E., Venturi, V., Davenport, M. P., Douek, D. C., Price, D. A., Kent, S. J.
(2008). Limited Maintenance of Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8 T-Cell Receptor Clonotypes after Virus Challenge. J. Virol.
82: 7357-7368
[Abstract]
[Full Text]
-
Rousseau, C. M., Daniels, M. G., Carlson, J. M., Kadie, C., Crawford, H., Prendergast, A., Matthews, P., Payne, R., Rolland, M., Raugi, D. N., Maust, B. S., Learn, G. H., Nickle, D. C., Coovadia, H., Ndung'u, T., Frahm, N., Brander, C., Walker, B. D., Goulder, P. J. R., Bhattacharya, T., Heckerman, D. E., Korber, B. T., Mullins, J. I.
(2008). HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load. J. Virol.
82: 6434-6446
[Abstract]
[Full Text]
-
Seki, S., Kawada, M., Takeda, A., Igarashi, H., Sata, T., Matano, T.
(2008). Transmission of Simian Immunodeficiency Virus Carrying Multiple Cytotoxic T-Lymphocyte Escape Mutations with Diminished Replicative Ability Can Result in AIDS Progression in Rhesus Macaques. J. Virol.
82: 5093-5098
[Abstract]
[Full Text]
-
Petravic, J., Loh, L., Kent, S. J., Davenport, M. P.
(2008). CD4+ Target Cell Availability Determines the Dynamics of Immune Escape and Reversion In Vivo. J. Virol.
82: 4091-4101
[Abstract]
[Full Text]
-
Peut, V., Kent, S. J.
(2007). Utility of Human Immunodeficiency Virus Type 1 Envelope as a T-Cell Immunogen. J. Virol.
81: 13125-13134
[Abstract]
[Full Text]
-
Liu, Y., McNevin, J., Zhao, H., Tebit, D. M., Troyer, R. M., McSweyn, M., Ghosh, A. K., Shriner, D., Arts, E. J., McElrath, M. J., Mullins, J. I.
(2007). Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape. J. Virol.
81: 12179-12188
[Abstract]
[Full Text]
-
Mandl, J. N., Regoes, R. R., Garber, D. A., Feinberg, M. B.
(2007). Estimating the Effectiveness of Simian Immunodeficiency Virus-Specific CD8+ T Cells from the Dynamics of Viral Immune Escape. J. Virol.
81: 11982-11991
[Abstract]
[Full Text]
-
Kuntzen, T., Timm, J., Berical, A., Lewis-Ximenez, L. L., Jones, A., Nolan, B., Schulze zur Wiesch, J., Li, B., Schneidewind, A., Kim, A. Y., Chung, R. T., Lauer, G. M., Allen, T. M.
(2007). Viral Sequence Evolution in Acute Hepatitis C Virus Infection. J. Virol.
81: 11658-11668
[Abstract]
[Full Text]
-
Karlsson, A. C., Chapman, J. M., Heiken, B. D., Hoh, R., Kallas, E. G., Martin, J. N., Hecht, F. M., Deeks, S. G., Nixon, D. F.
(2007). Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol. J. Virol.
81: 11543-11548
[Abstract]
[Full Text]
-
Rollman, E., Smith, M. Z., Brooks, A. G., Purcell, D. F. J., Zuber, B., Ramshaw, I. A., Kent, S. J.
(2007). Killing Kinetics of Simian Immunodeficiency Virus-Specific CD8+ T Cells: Implications for HIV Vaccine Strategies. J. Immunol.
179: 4571-4579
[Abstract]
[Full Text]
-
Crawford, H., Prado, J. G., Leslie, A., Hue, S., Honeyborne, I., Reddy, S., van der Stok, M., Mncube, Z., Brander, C., Rousseau, C., Mullins, J. I., Kaslow, R., Goepfert, P., Allen, S., Hunter, E., Mulenga, J., Kiepiela, P., Walker, B. D., Goulder, P. J. R.
(2007). Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection. J. Virol.
81: 8346-8351
[Abstract]
[Full Text]
-
Frater, A. J., Brown, H., Oxenius, A., Gunthard, H. F., Hirschel, B., Robinson, N., Leslie, A. J., Payne, R., Crawford, H., Prendergast, A., Brander, C., Kiepiela, P., Walker, B. D., Goulder, P. J. R., McLean, A., Phillips, R. E., and the Swiss HIV-Cohort Study,
(2007). Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression. J. Virol.
81: 6742-6751
[Abstract]
[Full Text]
-
Loh, L., Batten, C. J., Petravic, J., Davenport, M. P., Kent, S. J.
(2007). In Vivo Fitness Costs of Different Gag CD8 T-Cell Escape Mutant Simian-Human Immunodeficiency Viruses for Macaques. J. Virol.
81: 5418-5422
[Abstract]
[Full Text]
-
Fernandez, C. S., Smith, M. Z., Batten, C. J., De Rose, R., Reece, J. C., Rollman, E., Venturi, V., Davenport, M. P., Kent, S. J.
(2007). Vaccine-Induced T Cells Control Reversion of AIDS Virus Immune Escape Mutants. J. Virol.
81: 4137-4144
[Abstract]
[Full Text]
-
Asquith, B., McLean, A. R.
(2007). In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques. Proc. Natl. Acad. Sci. USA
104: 6365-6370
[Abstract]
[Full Text]
-
De Boer, R. J.
(2007). Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus. J. Virol.
81: 2838-2848
[Abstract]
[Full Text]
-
Regoes, R. R., Barber, D. L., Ahmed, R., Antia, R.
(2007). Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc. Natl. Acad. Sci. USA
104: 1599-1603
[Abstract]
[Full Text]
-
De Rose, R., Batten, C. J., Smith, M. Z., Fernandez, C. S., Peut, V., Thomson, S., Ramshaw, I. A., Coupar, B. E. H., Boyle, D. B., Venturi, V., Davenport, M. P., Kent, S. J.
(2007). Comparative Efficacy of Subtype AE Simian-Human Immunodeficiency Virus Priming and Boosting Vaccines in Pigtail Macaques. J. Virol.
81: 292-300
[Abstract]
[Full Text]
-
Li, B., Gladden, A. D., Altfeld, M., Kaldor, J. M., Cooper, D. A., Kelleher, A. D., Allen, T. M.
(2007). Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution. J. Virol.
81: 193-201
[Abstract]
[Full Text]
-
Martinez-Picado, J., Prado, J. G., Fry, E. E., Pfafferott, K., Leslie, A., Chetty, S., Thobakgale, C., Honeyborne, I., Crawford, H., Matthews, P., Pillay, T., Rousseau, C., Mullins, J. I., Brander, C., Walker, B. D., Stuart, D. I., Kiepiela, P., Goulder, P.
(2006). Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1.. J. Virol.
80: 3617-3623
[Abstract]
[Full Text]
-
Pastore, C., Nedellec, R., Ramos, A., Pontow, S., Ratner, L., Mosier, D. E.
(2006). Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations. J. Virol.
80: 750-758
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.